Eli Lilly and Company (LLY) Stock price, Description, News & Info

#Thinksabio latest news

Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting